Loading
Total declarations
Company
▲ Purchases (14 ops.)
▼ Sales (0 ops.)
Latest filing published 26 Dec 2024 for Immix Biopharma, Inc., €16k.
Filing timeline
BuySaleJason Hsu
Insider track record
Disclosed buys
14
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jason Hsu: trading record in brief
Jason Hsu (board member) discloses dealings in Immix Biopharma, Inc. to SEC (Form 4). We count 15 filings; the first trade dates from 20 December 2021 and the latest from 23 December 2024.
On the market, this insider has only ever bought: 14 purchases, €845k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2024 alone, the filings show 6 purchases and no sales.
Half of the purchases are above €27k and half below. Of 14 purchases, 8 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The record was last updated on 26 December 2024 with an open-market purchase (€84k) in Immix Biopharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jason Hsu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
7,700 shares@ US$2.1660.3% of flowCommon StockSEC:0001493152-24-052103:0
Canonical exit: 20 Mar 2025 (T+90)
15,000 shares@ US$2.2260.5% of flowCommon StockSEC:0001493152-24-033900:0
Canonical exit: 19 Nov 2024 (T+90)
3,200 shares@ US$2.07480.1% of flowCommon StockSEC:0001493152-24-029810:0
Canonical exit: 16 Oct 2024 (T+90)
25,000 shares@ US$4.8811.8% of flowCommon StockSEC:0001493152-23-044618:0
Canonical exit: 7 Mar 2024 (T+90)
25,000 shares@ US$2.89121.1% of flowCommon StockSEC:0001493152-23-032969:0
Canonical exit: 10 Dec 2023 (T+90)
10,000 shares@ US$2.53170.4% of flowCommon StockSEC:0001493152-23-032372:0
Canonical exit: 7 Dec 2023 (T+90)
3,915,913 shares@ US$0.8592.0% of flowCommon StockSEC:0001493152-21-032039:0
7 of 7 declarations
